In this week’s View, Dr. Eagle explores a UK Biobank study on triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease. He then discusses the risk of atrial and ventricular arrhythmia comparing carvedilol versus metoprolol among implantable cardioverter defibrillator recipients. Finally, Dr. Eagle examines the results from the ORION-5 randomized clinical trial that looked at the efficacy, safety, and tolerability of inclisiran in patients with homozygous familial hypercholesterolemia.
Subscribe to Eagle’s Eye View
Eagle's Eye View: Your Weekly CV Update From ACC.org